BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future. World J Gastroenterol 2014; 20(31): 10851-10863 [PMID: 25152587 DOI: 10.3748/wjg.v20.i31.10851]
URL: https://www.wjgnet.com/1007-9327/full/v20/i31/10851.htm
(322) (384) (0) (0) (13505) (94)
Number Citing Articles
1
Masayuki Mizuno, Toshihide Shima, Hirohisa Oya, Yasuhide Mitsumoto, Chiemi Mizuno, Satoshi Isoda, Mizue Kuramoto, Masanori Taniguchi, Masashi Noda, Kyoko Sakai, Noriyuki Koyama, Takeshi Okanoue. Classification of patients with non‐alcoholic fatty liver disease using rapid immunoassay of serum type IV collagen compared with liver histology and other fibrosis markers. Hepatology Research 2017; 47(2) doi: 10.1111/hepr.12710
2
Joaquín Reverter-Masia, Alvaro Pano-Rodriguez, Jose Vicente Beltran-Garrido, Albert Lecube, Enric Sánchez, Vicenç Hernández-González. Effect of a Training Program on Hepatic Fat Content and Cardiometabolic Risk in Postmenopausal Women: The Randomized Controlled Trial. Applied Sciences 2021; 11(14) doi: 10.3390/app11146409
3
Yong Zhang, Chao Wang, Yangyang Duanmu, Chenxin Zhang, Wei Zhao, Ling Wang, Xiaoguang Cheng, Nicola Veronese, Giuseppe Guglielmi. Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. The British Journal of Radiology 2018; 91(1091) doi: 10.1259/bjr.20170587
4
Joel Yeh Siang Chen, Damien Chua, Carissa Odelia Lim, Wan Xi Ho, Nguan Soon Tan. Lessons on Drug Development: A Literature Review of Challenges Faced in Nonalcoholic Fatty Liver Disease (NAFLD) Clinical Trials. International Journal of Molecular Sciences 2022; 24(1) doi: 10.3390/ijms24010158
5
Hirayuki Enomoto, Yukihiro Bando, Hideji Nakamura, Shuhei Nishiguchi, Masafumi Koga. Liver fibrosis markers of nonalcoholic steatohepatitis. World Journal of Gastroenterology 2015; 21(24): 7427-7435 doi: 10.3748/wjg.v21.i24.7427
6
Naohiko Nakamura, Etsuro Hatano, Kohta Iguchi, Motohiko Sato, Hiroaki Kawaguchi, Iwao Ohtsu, Takaki Sakurai, Nobuhiro Aizawa, Hiroko Iijima, Shuhei Nishiguchi, Takuya Tomono, Yukihiro Okuda, Seidai Wada, Satoru Seo, Kojiro Taura, Shinji Uemoto, Masaya Ikegawa. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5825-8
7
Cheng Hu, Tao Wang, Xiaoyu Zhuang, Qiaoli Sun, Xiaochun Wang, Hui Lin, Mingli Feng, Jiaqi Zhang, Qin Cao, Yuanye Jiang. Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry. Journal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-021-02820-7
8
Mah I Kan Changez, Maryam Mubeen, Monezahe Zehra, Inara Samnani, Aniqa Abdul Rasool, Anmol Mohan, Um Ul Wara, Usha Tejwaney, Vikash Kumar. Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review. Journal of International Medical Research 2023; 51(9) doi: 10.1177/03000605231197058
9
Cristini Escobar Viana, Vandreza Cardoso Bortolotto, Stífani Machado Araujo, Mustafa Munir Mustafa Dahleh, Franciéle Romero Machado, Adson de Souza Pereira, Byanca Pereira Moreira de Oliveira, Fernanda Vitória Leimann, Odinei Hess Gonçalves, Marina Prigol, Gustavo Petri Guerra. Lutein-loaded nanoparticles reverse oxidative stress, apoptosis, and autism spectrum disorder-like behaviors induced by prenatal valproic acid exposure in female rats. NeuroToxicology 2023; 94 doi: 10.1016/j.neuro.2022.12.006
10
Pantajaree Hiranrat, Surachate Siripongsakun, Kamonwan Soonklang. Correlation of ultrasound attenuation imaging versus MRI proton density fat fraction in non-alcoholic fatty liver. The ASEAN Journal of Radiology 2022; 23(3) doi: 10.46475/aseanjr.v23i3.185
11
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Non-invasive assessment of fatty liver. Orvosi Hetilap 2015; 156(14) doi: 10.1556/OH.2015.30123
12
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017;  doi: 10.1007/978-94-007-7675-3_37
13
A-Rang Im, Won-Kyung Yang, Yang-Chun Park, Seung Hyung Kim, Sungwook Chae. Hepatoprotective Effects of Insect Extracts in an Animal Model of Nonalcoholic Fatty Liver Disease. Nutrients 2018; 10(6) doi: 10.3390/nu10060735
14
Yu-Ning Gao, Mei-Ling Chen, Wen-Mao Li, Qing Liu, Yan Jiao. Advancing the diagnosis and treatment of metabolic-associated steatotic liver disease: The transformative role of artificial intelligence. Artificial Intelligence in Gastroenterology 2025; 6(1): 107105 doi: 10.35712/aig.v6.i1.107105
15
G. Craig Wood, Xin Chu, George Argyropoulos, Peter Benotti, David Rolston, Tooraj Mirshahi, Anthony Petrick, John Gabrielson, David J. Carey, Johanna K. DiStefano, Christopher D. Still, Glenn S. Gerhard. A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains. Scientific Reports 2017; 7(1) doi: 10.1038/srep43238
16
B. G. P. Koot, V. Nobili. Screening for non‐alcoholic fatty liver disease in children: do guidelines provide enough guidance?. Obesity Reviews 2017; 18(9) doi: 10.1111/obr.12556
17
Joao Miranda, Alexandre Key Wakate Teruya, Hilton Leão Filho, Daniel Lahan-Martins, Cássia Tamura Sttefano Guimarães, Vivianne de Paula Reis Guimarães, Fernando Ide Yamauchi, Roberto Blasbalg, Fernanda Garozzo Velloni. Diffuse and focal liver fat: advanced imaging techniques and diagnostic insights. Abdominal Radiology 2024; 49(12) doi: 10.1007/s00261-024-04407-4
18
Michael Hagan, Sumeet K Asrani, Jayant Talwalkar. Non-invasive assessment of liver fibrosis and prognosis. Expert Review of Gastroenterology & Hepatology 2015; 9(10) doi: 10.1586/17474124.2015.1075391
19
Wendy J. Bailey, Warren Glaab. Derisking drug-induced liver injury from bench to bedside. Current Opinion in Toxicology 2017; 4 doi: 10.1016/j.cotox.2017.06.006
20
A. Yu. Babenko, M. Yu. Laevskaya, A. R. Meltonian, Yu. N. Savchenkov, G. E. Trufanov. NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES: MODERN IMAGING MODALITIES. Translational Medicine 2023; 10(3) doi: 10.18705/2311-4495-2023-10-2-146-153
21
Patricia Quadros dos Santos, Raquel Rocha dos Santos, Carla Hilário da Cunha Daltro, Sandra Cristina de Souza Andrade, Helma Pinchemel Cotrim. Serum glutathione peroxidase is associated with nonalcoholic fatty liver disease in children and adolescents. Nutrición Hospitalaria 2024;  doi: 10.20960/nh.05105
22
Narriane C. P. Holanda, Amanda R. L. Oliveira, Nara N. C. Carvalho, Bruno L. Souza. Endocrinology and Diabetes. 2022;  doi: 10.1007/978-3-030-90684-9_42
23
Anna F. Sheptulina, E. N. Shirokova, V. T. Ivashkin. Non-invasive methods for diagnostics of liver fibrosis in patients with autoimmune hepatitis and autoimmune hepatitis - primary biliary cirrhosis. Clinical Medicine (Russian Journal) 2017; 94(11) doi: 10.18821/0023-2149-2016-94-11-843-850
24
Emer Fitzpatrick. Understanding susceptibility and targeting treatment in non-alcoholic fatty liver disease in children; moving the fulcrum. Proceedings of the Nutrition Society 2019; 78(3) doi: 10.1017/S0029665118002914
25
Meng-Tsz Tsai, Yu-Jen Chen, Ching-Yi Chen, Mong-Hsun Tsai, Chia-Li Han, Yu-Ju Chen, Harry J Mersmann, Shih-Torng Ding. Identification of Potential Plasma Biomarkers for Nonalcoholic Fatty Liver Disease by Integrating Transcriptomics and Proteomics in Laying Hens. The Journal of Nutrition 2017; 147(3) doi: 10.3945/jn.116.240358
26
Walaa Abdelhamed, Mohamed Elbadry, Mohamed El-Kassas. Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond. Liver Research 2026;  doi: 10.1016/j.livres.2026.05.001
27
Qian Li, Manish Dhyani, Joseph R Grajo, Claude Sirlin, Anthony E Samir. Current status of imaging in nonalcoholic fatty liver disease. World Journal of Hepatology 2018; 10(8): 530-542 doi: 10.4254/wjh.v10.i8.530
28
Kushila Rupasinghe, Jonathan Hind, Robert Hegarty. Updates in Metabolic Dysfunction‐Associated Fatty Liver Disease (MAFLD) in Children. Journal of Pediatric Gastroenterology and Nutrition 2023; 77(5) doi: 10.1097/MPG.0000000000003919
29
Sudhakar K. Venkatesh. Imaging in MASLD. Expert Review of Gastroenterology & Hepatology 2026; 20(3) doi: 10.1080/17474124.2026.2636184
30
Tomasz Kostrzewski, Terri Cornforth, Sophie A Snow, Larissa Ouro-Gnao, Cliff Rowe, Emma M Large, David J Hughes. Three-dimensional perfused human <i>in vitro</i> model of non-alcoholic fatty liver disease. World Journal of Gastroenterology 2017; 23(2): 204-215 doi: 10.3748/wjg.v23.i2.204
31
James Day, Preya Patel, Julie Parkes, William Rosenberg. Derivation and Performance of Standardized Enhanced Liver Fibrosis (ELF) Test Thresholds for the Detection and Prognosis of Liver Fibrosis. The Journal of Applied Laboratory Medicine 2019; 3(5) doi: 10.1373/jalm.2018.027359
32
Jake P Mann, Rajiv Goonetilleke, Pat McKiernan. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. Archives of Disease in Childhood 2015; 100(7) doi: 10.1136/archdischild-2014-307985
33
WEI CHEN, XIAOWEI WANG, LI HUANG, BO LIU. Hepcidin in non-alcoholic fatty liver disease regulated by the TLR4/NF-κB signaling pathway. Experimental and Therapeutic Medicine 2016; 11(1) doi: 10.3892/etm.2015.2873
34
Krasimira Aleksandrova, Sabrina Schlesinger, Marta Stelmach-Mardas. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2016;  doi: 10.1007/978-94-007-7742-2_37-1
35
Farkhonde Razmpour, Mohsen Nematy, Mahmoud Belghaisi Naseri, Zahra Dehnavi, Azita Ganji, Hasan Ali Vatanparast, Ali Taghipour, Mohsen Azimi Nezhad, Seyed Ali Alamdaran. Which Method is Superior in the Diagnosis of Nonalcoholic Fatty Liver and Steatohepatatis in Children?. Hepatitis Monthly 2017; 17(10) doi: 10.5812/hepatmon.13584
36
Cornelius von Morze, James Tropp, Albert P. Chen, Irene Marco‐Rius, Mark Van Criekinge, Timothy W. Skloss, Daniele Mammoli, John Kurhanewicz, Daniel B. Vigneron, Michael A. Ohliger, Matthew E. Merritt. Sensitivity enhancement for detection of hyperpolarized 13C MRI probes with 1H spin coupling introduced by enzymatic transformation in vivo. Magnetic Resonance in Medicine 2018; 80(1) doi: 10.1002/mrm.27000
37
Sumeet K. Asrani. Incorporation of Noninvasive Measures of Liver Fibrosis Into Clinical Practice: Diagnosis and Prognosis. Clinical Gastroenterology and Hepatology 2015; 13(12) doi: 10.1016/j.cgh.2015.07.030
38
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. Pharmaceutical Medicine 2019; 33(6) doi: 10.1007/s40290-019-00305-z
39
Amreen M. Dinani, Sara Lewis, Andrea D. Branch, Ponni Perumalswami. Working Up an Incidental Finding of Hepatic Steatosis on Imaging. Clinical Liver Disease 2020; 16(2) doi: 10.1002/cld.926
40
Karthik Kolluru, Anamika Giri, Sunil Kumar, Sourya Acharya, Sachin Agrawal, Anil Wanjari, Shilpa A Gaidhane. Association of Metabolic-Associated Fatty Liver Disease With Various Anthropometric Parameters in Pre-diabetes in Comparison With Diabetes and Control: A Single Tertiary Care Center Study. Cureus 2022;  doi: 10.7759/cureus.27130
41
Sarah Esmaeilpour, Farshad Sheikhesmaili, Mohammad Moradzad, Bijan Noori, Mohammad Abdi, Zakaria Vahabzadeh. The diagnostic value of miRNAs combination for Kurdish NAFLD patients. Advances in Biomarker Sciences and Technology 2025; 7 doi: 10.1016/j.abst.2025.11.004
42
Andreas J. Hülsmeier, Micha Tobler, Patricie Burda, Thierry Hennet. Glycosylation site occupancy in health, congenital disorder of glycosylation and fatty liver disease. Scientific Reports 2016; 6(1) doi: 10.1038/srep33927
43
Tilman Kühn, Tobias Nonnenmacher, Disorn Sookthai, Ruth Schübel, Daniel Antonio Quintana Pacheco, Oyunbileg von Stackelberg, Mirja E. Graf, Theron Johnson, Christopher L. Schlett, Romy Kirsten, Cornelia M. Ulrich, Rudolf Kaaks, Hans-Ulrich Kauczor, Johanna Nattenmüller. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults. BMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0840-9
44
Shivakumar Chitturi, Geoffrey C. Farrell. Textbook of Diabetes. 2017;  doi: 10.1002/9781118924853.ch51
45
Nurgul A. Toktogulova, Roza B. Sultanalieva, Rustam R. Tuhvatshin, Turarbek K. Kaliev. Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions. Terapevticheskii arkhiv 2023; 94(12) doi: 10.26442/00403660.2022.12.201998
46
Alessandra Carvalho Goulart, Ilka Regina Souza de Oliveira, Airlane Pereira Alencar, Maira Solange Camara dos Santos, Itamar Souza Santos, Brenda Margatho Ramos Martines, Danilo Peron Meireles, João Augusto dos Santos Martines, Giovanni Misciagna, Isabela Martins Benseñor, Paulo Andrade Lotufo. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Sao Paulo Medical Journal 2015; 133(2) doi: 10.1590/1516-3180.2014.9150812
47
Karn Wijarnpreecha, Charat Thongprayoon, Melissa Scribani, Patompong Ungprasert, Wisit Cheungpasitporn. Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA. European Journal of Gastroenterology & Hepatology 2018; 30(4) doi: 10.1097/MEG.0000000000001045
48
Eugenia Tsai, Tai-Ping Lee. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Clinics in Liver Disease 2018; 22(1) doi: 10.1016/j.cld.2017.08.004
49
A New Clinical Spectrum for the Assessment of Nonalcoholic Fatty Liver Disease Using Intelligent Methods. IEEE Access 2020; 8 doi: 10.1109/ACCESS.2020.3011289
50
A. F. Sheptulina, Ye. N. Shirokova, V. T. Ivashkin. Noninvasive diagnostic methods of liver fibrosis in patients with primary biliary cirrhosis and primary sclerosing cholangitis: role of indirect serological markers. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2016; 26(3) doi: 10.22416/1382-4376-2016-26-3-52-63
51
Lizhi Fu, Antje Bruckbauer, Fenfen Li, Qiang Cao, Xin Cui, Rui Wu, Hang Shi, Michael B. Zemel, Bingzhong Xue. Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice. Metabolism 2015; 64(11) doi: 10.1016/j.metabol.2015.07.006
52
Tomasz Kostrzewski, Paloma Maraver, Larissa Ouro‐Gnao, Ana Levi, Sophie Snow, Alina Miedzik, Krista Rombouts, David Hughes. A Microphysiological System for Studying Nonalcoholic Steatohepatitis. Hepatology Communications 2020; 4(1) doi: 10.1002/hep4.1450
53
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4
54
William Alazawi, Eduardo Bernabe, David Tai, Tomasz Janicki, Polychronis Kemos, Salma Samsuddin, Wing-Kin Syn, David Gillam, Wendy Turner, Giovanni Targher. Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease. PLOS ONE 2017; 12(12) doi: 10.1371/journal.pone.0185902
55
Gala Martín-Pozuelo, Rocío González-Barrio, Gonzalo Barberá, Amaya Albalat, Javier García-Alonso, William Mullen, Harald Mischak, María Periago. Tomato Juice Consumption Modifies the Urinary Peptide Profile in Sprague-Dawley Rats with Induced Hepatic Steatosis. International Journal of Molecular Sciences 2016; 17(11) doi: 10.3390/ijms17111789
56
Manuel Suárez, Noemí Boqué, Josep Del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver Disease. Nutrients 2017; 9(10) doi: 10.3390/nu9101052
57
Mirko Zoncapè, Antonio Liguori, Emmanuel A. Tsochatzis. Non-invasive testing and risk-stratification in patients with MASLD. European Journal of Internal Medicine 2024; 122 doi: 10.1016/j.ejim.2024.01.013
58
Haruka Hirono, Kazuhiko Watanabe, Katsuhiko Hasegawa, Shogo Ohkoshi. Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population. Journal of Clinical and Translational Hepatology 2019; 7(2) doi: 10.14218/JCTH.2018.00048
59
Mesbah Uddin Ahmed. Association of Serum Cytokeratin-18 Fragment Concentration in Patients with Different Types of Nonalcoholic Fatty Liver Disease. Gastroenterology & Hepatology : Open Access 2015; 2(2) doi: 10.15406/ghoa.2015.02.00037
60
Chetan Mandelia, Mohammad Nasser Kabbany, Praveen Kumar Conjeevaram Selvakumar, Naim Alkhouri. The Search for Noninvasive Methods to Identify Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease. Biomarkers in Medicine 2018; 12(3) doi: 10.2217/bmm-2017-0038
61
Maciej Adler, Licia Larocca, Francesca M. Trovato, Heather Marcinkowski, Yasmin Pasha, Simon D. Taylor-Robinson. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study. HPB 2016; 18(8) doi: 10.1016/j.hpb.2016.05.005
62
Oliver Glass, Ricardo Henao, Keyur Patel, Cynthia D. Guy, Hans J. Gruss, Wing‐Kin Syn, Cynthia A. Moylan, Robert Streilein, Russell Hall, Anna Mae Diehl, Manal F. Abdelmalek. Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Hepatology Communications 2018; 2(11) doi: 10.1002/hep4.1237
63
RN Williams, C Filozof, BJ Goldstein, K Cusi. Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development program. Clinical Pharmacology & Therapeutics 2017; 101(4) doi: 10.1002/cpt.560
64
Daiane Teixeira de Oliveira, Renata Guerra-Sá. Uncovering epigenetic landscape: a new path for biomarkers identification and drug development. Molecular Biology Reports 2020; 47(11) doi: 10.1007/s11033-020-05916-3
65
Takeshi Okanoue, Hayao Ebise, Toshihiro Kai, Masayuki Mizuno, Toshihide Shima, Junji Ichihara, Mikio Aoki. A simple scoring system using type IV collagen 7S and aspartate aminotransferase for diagnosing nonalcoholic steatohepatitis and related fibrosis. Journal of Gastroenterology 2018; 53(1) doi: 10.1007/s00535-017-1355-9
66
Christiane S. Hampe, Michele L. Shaffer, Christian L. Roth. Associations between Liver Enzyme Levels and Parameters of the Metabolic Syndrome in Obese Children. Hormone Research in Paediatrics 2017; 88(3-4) doi: 10.1159/000479868
67
Christos Spanos, Elaina M. Maldonado, Ciarán P. Fisher, Petchpailin Leenutaphong, Ernesto Oviedo-Orta, David Windridge, Francisco J. Salguero, Alexandra Bermúdez-Fajardo, Mark E. Weeks, Caroline Evans, Bernard M. Corfe, Naila Rabbani, Paul J. Thornalley, Michael H. Miller, Huan Wang, John F. Dillon, Alberto Quaglia, Anil Dhawan, Emer Fitzpatrick, J. Bernadette Moore. Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver disease. Proteome Science 2018; 16(1) doi: 10.1186/s12953-018-0131-y
68
Naoyuki Fujimori, Naoki Tanaka, Soichiro Shibata, Kenji Sano, Tomoo Yamazaki, Tomohiro Sekiguchi, Hiroyuki Kitabatake, Yuki Ichikawa, Takefumi Kimura, Michiharu Komatsu, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka. Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non‐alcoholic fatty liver disease with none‐to‐mild obesity and liver fibrosis. Hepatology Research 2016; 46(10) doi: 10.1111/hepr.12649
69
Yuqing Ma, Changzhi Zhang, Meng Tian, Jie Hu, MiaoJuan Wang, Shan Liu. Non‐invasive diagnosis of metabolic dysfunction‐associated steatotic liver disease: Current status, challenges, and future directions. Diabetes, Obesity and Metabolism 2026; 28(3) doi: 10.1111/dom.70326
70
Nasrin Sharifi, Reza Amani. Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials. Critical Reviews in Food Science and Nutrition 2019; 59(4) doi: 10.1080/10408398.2017.1389693
71
Emer Fitzpatrick, Anil Dhawan. Childhood and Adolescent Nonalcoholic Fatty Liver Disease: Is It Different from Adults?. Journal of Clinical and Experimental Hepatology 2019; 9(6) doi: 10.1016/j.jceh.2019.05.005
72
Getnet Teshome, Sintayehu Ambachew, Alebachew Fasil, Molla Abebe. <p>Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review</p>. Hepatic Medicine: Evidence and Research 2020;  doi: 10.2147/HMER.S265631
73
Pooja Dudeja, Taishee Pal, Aman Sharma. The novel approach for non-invasive diagnostic biomarkers from an early stage of NAFLD to advanced fibrosis. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00287-3
74
Natalia Nuño-Lámbarri, Varenka Barbero-Becerra, Misael Uribe, Norberto Chávez-Tapia. Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach. International Journal of Molecular Sciences 2016; 17(3) doi: 10.3390/ijms17030281
75
Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu, Gabriela Ștefănescu. Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease. Metabolites 2023; 13(11) doi: 10.3390/metabo13111115
76
S. Tsiomita, U. Georgopoulou, P.P. Doumba, J. Koskinas, K. Adamidis, C. Papaloukas, G. Thyphronitis. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infection. Infection, Genetics and Evolution 2018; 58 doi: 10.1016/j.meegid.2017.12.002
77
Ebrahim Banitalebi, Mohammad Faramarzi, Samira Nasiri, Majid Mardaniyan, Vahid Rabiee. Effects of different exercise modalities on novel hepatic steatosis indices in overweight women with type 2 diabetes. Clinical and Molecular Hepatology 2019; 25(3) doi: 10.3350/cmh.2018.0086
78
Gajanan A. Rodge, Mahesh K. Goenka, Usha Goenka, Shivaraj Afzalpurkar, Bhavik B. Shah. Quantification of Liver Fat by MRI-PDFF Imaging in Patients with Suspected Non-alcoholic Fatty Liver Disease and Its Correlation with Metabolic Syndrome, Liver Function Test and Ultrasonography. Journal of Clinical and Experimental Hepatology 2021; 11(5) doi: 10.1016/j.jceh.2020.11.004
79
Stefania Di Mauro, Alessandra Scamporrino, Agnese Filippello, Antonino Di Pino, Roberto Scicali, Roberta Malaguarnera, Francesco Purrello, Salvatore Piro. Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. International Journal of Molecular Sciences 2021; 22(21) doi: 10.3390/ijms222111905
80
Tavitiya Sudjaritruk, Torsak Bunupuradah, Linda Aurpibul, Pope Kosalaraksa, Nia Kurniati, Jiratchaya Sophonphan, Panruethai Trinavarat, Pannee Visrutaratna, Jiraporn Srinakarin, Nataruks Chaijitraruch, Thanyawee Puthanakit, Wing-Kin Syn. Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy. PLOS ONE 2019; 14(12) doi: 10.1371/journal.pone.0226375
81
Nimish Thakral, Hailemichael Desalegn, Luis Antonio Diaz, Daniel Cabrera, Rohit Loomba, Marco Arrese, Juan Pablo Arab. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD. Seminars in Liver Disease 2024; 44(03) doi: 10.1055/a-2364-2928
82
Kai-Lun Shih, Wei-Wen Su, Chia-Chu Chang, Chew-Teng Kor, Chen-Te Chou, Ting-Yu Chen, Hung-Ming Wu. Comparisons of parallel potential biomarkers of 1H-MRS-measured hepatic lipid content in patients with non-alcoholic fatty liver disease. Scientific Reports 2016; 6(1) doi: 10.1038/srep24031
83
Ming-Ying Lu, Yu-Ju Wei, Chih-Wen Wang, Po-Cheng Liang, Ming-Lun Yeh, Yi-Shan Tsai, Pei-Chien Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yi-Hung Lin, Tyng-Yuan Jang, Ming-Yen Hsieh, Zu-Yau Lin, Chung-Feng Huang, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu. Mitochondrial mt12361A&gt;G increased risk of metabolic dysfunction-associated steatotic liver disease among non-diabetes. World Journal of Gastroenterology 2025; 31(10): 103716 doi: 10.3748/wjg.v31.i10.103716
84
Nahum Calvo, Ra&uacute;l Beltr&aacute;n-Deb&oacute;n, Esther Rodr&iacute;guez-Gallego, Anna Hern&aacute;ndez-Aguilera, Maria Guirro, Roger Marin&eacute;-Casad&oacute;, Lid&oacute;n Mill&aacute;, Josep M Alegret, F&agrave;tima Sabench, Daniel del Castillo, Mar&iacute;a Vinaixa, Miguel &Agrave;ngel Rodr&iacute;guez, Xavier Correig, Roberto Garc&iacute;a-&Aacute;lvarez, Javier A Menendez, Jordi Camps, Jorge Joven. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology. World Journal of Gastroenterology 2015; 21(24): 7529-7544 doi: 10.3748/wjg.v21.i24.7529
85
Yasuyo Urasaki, Chi Zhang, Ji-Xin Cheng, Thuc T. Le. Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22082-6
86
S. Di Mauro, M. Ragusa, F. Urbano, A. Filippello, A. Di Pino, A. Scamporrino, A. Pulvirenti, A. Ferro, A.M. Rabuazzo, M. Purrello, F. Purrello, S. Piro. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications. Nutrition, Metabolism and Cardiovascular Diseases 2016; 26(12) doi: 10.1016/j.numecd.2016.08.004
87
Li Wang, Yuning Pan, Xianwang Ye, Yongmeng Zhu, Yandong Lian, Hui Zhang, Miao Xu, Mengxiao Liu, Xinzhong Ruan. Perirenal fat thickness and liver fat fraction are independent predictors of MetS in adults with overweight and obesity suspected with NAFLD: a retrospective study. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01033-w
88
Vasile-Andrei Olteanu, Gheorghe G. Balan, Oana Timofte, Cristina Gena Dascalu, Elena Gologan, Georgiana-Emanuela Gilca-Blanariu, Madalina-Maria Diac, Ion Sandu, Gabriela Stefanescu. Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease. Diagnostics 2022; 12(9) doi: 10.3390/diagnostics12092136
89
Anna Egresi, Anna Blázovics, Gabriella Lengyel, Adrienn Gréta Tóth, Barbara Csongrády, Zsuzsanna Jakab, Krisztina Hagymási. Redox Homeostasis and Non-Invasive Assessment of Significant Liver Fibrosis by Shear Wave Elastography. Diagnostics 2024; 14(17) doi: 10.3390/diagnostics14171945
90
I. M. Petrov, I. V. Medvedeva, I. F. Sholomov, L. V. Chesnokova , Yu. A. Petrova, V. A. Snezhitskiy, L. V. Kalatsei, А. V. Gladkevich. BIOMARKERS OF CARDIOVASCULAR RISK IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE. Journal of the Grodno State Medical University 2020; 18(3) doi: 10.25298/2221-8785-2020-18-3-236-242
91
Deirdre Kelly, Henkjan J. Verkade, Jeremy Rajanayagam, Patrick McKiernan, George Mazariegos, Stefan Hübscher. Late graft hepatitis and fibrosis in pediatric liver allograft recipients: Current concepts and future developments. Liver Transplantation 2016; 22(11) doi: 10.1002/lt.24616
92
Maria Grazia Clemente, Claudia Mandato, Marco Poeta, Pietro Vajro. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions. World Journal of Gastroenterology 2016; 22(36): 8078-8093 doi: 10.3748/wjg.v22.i36.8078
93
Shreya Pandey, Deeksha Marwari, Jiya Mishra, Amit Goel, Ajay Kumar Mishra, Neeraj Sinha. NMR‐Based Metabolomics Reveals Metabolic Pathway Disruptions and Potential Biomarkers for Fibrosis. Magnetic Resonance in Chemistry 2025; 63(10) doi: 10.1002/mrc.70017
94
Robert Ross, Simrat Soni, Sarah Houle. Negative Energy Balance Induced by Exercise or Diet: Effects on Visceral Adipose Tissue and Liver Fat. Nutrients 2020; 12(4) doi: 10.3390/nu12040891
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.